Suppr超能文献

血压变异性与卒中风险:来自开滦队列研究的结果。

Visit-to-visit Variability of Blood Pressure and Risk of Stroke: Results of the Kailuan Cohort Study.

机构信息

Center of Clinical Pharmacology, the Third Xiangya Hospital, Central South University, Changsha, China.

Department of Cardiology, the Third Xiangya Hospital, Central South University, Changsha, China.

出版信息

Sci Rep. 2017 Mar 21;7(1):285. doi: 10.1038/s41598-017-00380-9.

Abstract

Uncertainty persists regarding the need to address blood pressure (BP) variability in the general population to reduce the heavy burden of stroke. In this cohort study, we prospectively recruited 57,927 participants from southeast of Beijing, who have completed all 3 health examinations between 2006 and 2010. BP variability was defined as the coefficient of variation (CV) across these 3 visits. Over a median follow-up of 3.0 years, we identified 582 first stroke cases. Of these, 489 (84.0%) were ischemic strokes and 94 (16.2%) were hemorrhagic strokes. After multivariable adjustment, the hazard ratios (HR) (95% Confidence Intervals, CI) of comparing participants in the highest versus lowest quartile of CV of systolic blood pressure (SBP) was 1.44 (1.11, 1.87) for any stroke, 1.33 (1.00, 1.77) for ischemic stroke, and 2.17 (1.09, 4.35) for hemorrhagic stroke. Similar results were also observed when the CV of SBP was considered as a continuous exposure variable (per SD increase). Moreover, higher variability of diastolic blood pressure (DBP) was also significantly associated with the risk of any stroke and specifically with hemorrhagic stroke, but not with ischemic stroke. In conclusion, higher visit-to-visit BP variability might be an important target to reduce stroke risk, particularly for hemorrhagic stroke.

摘要

血压变异性与人群卒中负担

前瞻性研究

血压变异性与人群卒中负担

前瞻性研究

在一般人群中,降低卒中的沉重负担是否需要控制血压(BP)变异性仍存在不确定性。在这项队列研究中,我们前瞻性地招募了 57927 名来自北京东南部的参与者,他们在 2006 年至 2010 年间完成了所有 3 次健康检查。BP 变异性定义为这 3 次就诊的变异系数(CV)。在中位随访 3.0 年期间,我们确定了 582 例首发卒中病例。其中,489 例(84.0%)为缺血性卒中,94 例(16.2%)为出血性卒中。在多变量调整后,比较收缩压(SBP)CV 最高四分位与最低四分位的参与者的风险比(HR)(95%置信区间,CI)为任何卒中 1.44(1.11,1.87),缺血性卒中 1.33(1.00,1.77),出血性卒中 2.17(1.09,4.35)。当 SBP 的 CV 被视为连续暴露变量(每增加一个标准差)时,也观察到了类似的结果。此外,舒张压(DBP)变异性较高也与任何卒中风险以及特别是出血性卒中风险显著相关,但与缺血性卒中无关。总之,较高的随访间 BP 变异性可能是降低卒中风险的一个重要目标,特别是对出血性卒中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bcb/5428298/e6145d95e7d6/41598_2017_380_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验